Roberta Cagini

Suggest Changes
We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Introduction: Persistence and adherence rates assessed for various drugs for Overactive Bladder (OAB) in real-world settings are dramatically poor, with almost 70% to 90% of patients discontinuing(More)
  • 1